|
Market Research Reports
|
| International Congress of Antibodies 2010 |
|
|
Time: March 24-26, 2010
Place: Beijing, China
|
| ICA-2010 will provide a platform for participants to: |
|
 |
Learn the latest technologies and developments for antibodies |
|
| |
Comprehend the best strategies to follow in order to optimally plan antibodies R & D |
| |
Gain insights from industry decision makers as they share their thoughts on market trend |
| |
Hear opinions from professionals about regulatory issues and policies on antibodies |
| |
Build partnerships in China and beyond to catch your targets |
| |
Find huge opportunities and markets for your business |
|
| Programmed Sessions at a Glance |
|
|
|
 Event Report |
|
 |
The 1st Annual International Congress of Antibodies 2009 was hold successfully in International Convention Center, Beijing, China during May 22-24, 2009. The conference was supported by China Medicinal Biotech Association (CMBA), P.R. China; GenScript Corporation, USA; and Buchang Pharmacy Group, P.R. China.
|
 |
 |
 |
|
| Conference Exhibition |
For Sponsors |
Exhibition Date
Set-up date: March 23 (Tuesday)
Show dates:
March 24 (Wednesday)-26 (Friday), 09:00-18:00
Place: Exhibition Hall, Floor 3, Beijing International Convention Center
Space: 3m (W) x 2m (D) x 2.5m (H)
|
Exposure to 200 interested and relevant world class scientists, executives and decision makers on frontier of antibody industry and antibody R&D, and over 350 participants:
· Opportunities to focus on strategic issues in the antibody industry, explore ways to further your products and technologies, and make new contacts through several organized networking events
· Demonstrate and promote new products, introduce new services or solutions and engage face-to-face contact with your target audience
|
|
|
| Silver Sponsor |
|
|
 |
| Renowned Speakers |
|
|
|
 |
Dr. Tony Warford
Discipline Leader, AstraZeneca, Innovation Center China, China |
|
|
|
 |
Dr. Steffen Nock
Acting CEO, Arana Therapeutics, USA |
|
|
|
 |
Dr. Wolfgang Teschner
Director Research, Plasma Product Development / Product Support, Global Pre-clinical R&D, Baxter Innovations GmbH, Germany |
|
|
|
 |
Dr. Masa Fujiwara
President&CEO, Chiome Bioscience Inc.,Japan |
|
|
|
 |
Dr. Tom Smart
Chairman & CEO, AnaptysBio, Inc., USA |
|
|
|
|
Dr. Teodor Aastrup
CEO, Attana AB, Sweden |
|
|
|
|
Dr. Timothy S. Zheng
Principal Scientist & Scientific Evaluation Liaison, Biogen Idec, Inc., UK |
|
|
|
|
Dr. Ewa Pol
Scientist, GE Heathcare Life Sciences, Sweden |
|
|
|
|
Dr. Daniel Chain
Chairman and CEO, Intellect Neurosciences, Inc., USA |
|
|
|
|
Dr. Chris Ullman
CSO, Isogenica Ltd., UK |
|
|
|
 |
Dr. John V. Oyler
CEO and Founder, Bioduro, USA |
|
|
|
 |
Dr. Frank Zhang
CEO, GenScript Corporation, USA |
|
|
|
 |
Dr. Evan B. Siegel
President and CEO, Ground Zero Pharmaceuticals, Inc., USA |
|
|
|
 |
Dr. Leodevico (Vic) L. Ilag
COO, Patrys Ltd, Australia |
|
|
|
 |
Dr. Andreas Baumann
Principal Scientific Expert Biologics, Bayer Schering Pharma AG, Germany |
|
|
|
| Attendees list |
|
Arana Therapeutics
Attana AB
Amgen
Biogen Idec, Inc.
Bayer Schering Pharma AG
Baxter Innovations GmbH
Burrill & Company
Centocor R&D, Inc.
Crucell NV
Chiome Bioscience Inc.
Epitomics Inc.
Bioduro
GSK-Domantis Ltd.
GenScript Corporation
Genmab
Ground Zero Pharmaceuticals, Inc.
GlaxoSmithKline Biologicals
GE Heathcare Life Sciences
Human Antibodomics Inc.
Isogenica Ltd.
Intellect Neurosciences, Inc.
ImClone Systems Inc.
Medarex Inc.
MitoSciences Inc.
Millipore Corporation
MacroGenics Inc.
Merck & Co., Inc.
NPS Pharmaceuticals
Patrys Ltd.
PX'Therapeutics SA
Pfizer Global Biologics
Roche Global Pharma Partnering
Seattle Genetics, Inc.
SuppreMol GmbH
Tracon Pharma
Trillium Diagnostics, LLC
Wyeth Research |
|
|
| Organization |
|
|
|
| Operating |
|
 |
Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision
BIT Lifesciences, Inc. |
|
|
| International Marketing Partner |
|
|
|
| Partners |
|
|
|
|
|
Home
